Evaluation of annexin A5 as a biomarker for Alzheimer's disease and dementia with lewy bodies - Concepedia

Concepedia

Publication | Open Access

Evaluation of annexin A5 as a biomarker for Alzheimer's disease and dementia with lewy bodies

DOI Full Paper Access

35

Citations

34

References

2013

Year

Hitoshi Sohma, Shin-ichi Imai, Norio Takei, Hirohito Honda, Kyoichi Matsumoto, Kumiko Utsumi, Kayo Matsuki, Eri Hashimoto, Toshikazu Saito, Yasuo Kokai

Frontiers in Aging Neuroscience

Abstract

These results suggest that both annexin A5 and ApoE4 are common markers for AD and DLB.

References

	Year	Citations
Clinical diagnosis of Alzheimer's disease Guy M. McKhann, David A. Drachman, Marshall Folstein, Neurology	1984	27.8K
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Clifford R. Jack, David S. Knopman, William J. Jagust, The Lancet Neurology Alzheimer's DiseaseDementiaBiomarkersVascular DementiaNeurochemical Biomarkers	2009	4.6K
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. D.T. Vernier Journal of Lipid Research	1990	2.9K
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Guy M. McKhann, David A. Drachman, Marshall Folstein, Neurology	2011	1.5K
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders Irene Litvan, Kailash P. Bhatia, David J. Burn, Movement Disorders Motor DysfunctionNeurological DisorderCorticobasal DegenerationMultiple System AtrophyDiagnosis	2003	1K
Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding Karin M. Danzer, Dorothea Haasen, Anne R. Karow, Journal of Neuroscience Prefibrillar OligomersNeurodegenerative DiseasesMolecular NeuroscienceBiochemistryMedicine	2007	782
Dementia with Lewy bodies. Ian G. McKeith PubMed Dlb PatientsCorticobasal DegenerationNeurochemical BiomarkersOlder PeopleSocial Sciences	2004	760
Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice Niels Andreasen, Lennart Minthon, Pia Davidsson, Archives of Neurology	2001	570
Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia Anoop Varma, Julie S. Snowden, J. J. Lloyd, Journal of Neurology Neurosurgery & Psychiatry	1999	400
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration Brit Mollenhauer, Valerie Cullen, Ilana Kahn, Experimental Neurology Neurodegenerative DiseasesNeurobiology Of DiseaseMedicineBiomarkersDegenerative Pathology	2008	384

Page 1